Research / POLA / Fundamental state Inspectable configuration
State dimensions Filing 0001641172-25-001504 General Corporate
Capex intensity 12th Own-history percentile · N=17
Evidence method Level · gp.fundamentals.capex_revenue_ratio
0.14% · OPTIONAL · VALID
Operating cash generation 95th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-3.84% · OPTIONAL · VALID
Revenue growth 40th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-8.65% · CORE · VALID
Inventory pressure 10th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
92.29% · OPTIONAL · VALID
Gross margin 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
9.41% · CORE · VALID
Operating margin 50th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
-31.32% · CORE · VALID
R&D intensity 10th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
5.52% · OPTIONAL · VALID
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
17.07% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 34 states Self-history eligible
Sep 30, 2021 6/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/8 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 6/6 normalized Level 3 Jun 30, 2023 6/6 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/8 normalized Level 3 Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 3 Dec 31, 2025 7/7 normalized Level 3 Mar 31, 2026 7/7 normalized Level 3 Jun 30, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 0.00%
Current 0.14%
Delta 0.14% Cash Generation Increased
Previous -12.01%
Current -3.84%
Delta 8.17% Growth Decreased
Previous 157.14%
Current -8.65%
Delta -165.79% Inventory Pressure Decreased
Previous 305.84%
Current 92.29%
Delta -213.55% Margin Decreased
Previous 28.98%
Current 9.41%
Delta -19.57% Profitability Decreased
Previous 0.81%
Current -31.32%
Delta -32.13% R And D Intensity Increased
Previous 3.50%
Current 5.52%
Delta 2.02% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.